Related Experiment Video
Updated: May 24, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Synchronous Isolated Cystic Pancreatic Metastasis Arising From Primary Colorectal Cancer: A Rare Case Report
Reem Mubarak1, Samah Mohamed2,3, Rajen Goyal1
1Department of Hepato-Pancreato-Biliary (HPB) Surgery, Hamad Medical Corporation, Doha, Qatar.
The American Journal of Case Reports
|May 22, 2026
Summary
Pancreatic metastasis from colorectal cancer is rare. Surgical resection is the primary treatment, offering improved outcomes and palliation for patients with secondary pancreatic cancer.
Area of Science:
- Oncology
- Gastroenterology
- Surgical Oncology
Background:
- Pancreatic cancer is a significant cause of cancer death globally.
- Metastatic tumors to the pancreas are rare (1-2%), with renal cell carcinoma being the most common primary source.
- Pancreatic metastases from colorectal cancer are exceedingly rare, with unclear clinical behavior, management, and prognosis.
Purpose of the Study:
- To report a rare case of pancreatic metastasis originating from colorectal cancer.
- To detail the management of this rare condition.
- To enhance understanding and guide future care for similar cases.
Main Methods:
- A case report of a 70-year-old male with rectal adenocarcinoma presenting with a pancreatic lesion.
- Diagnostic evaluations included colonoscopy, biopsy, staging, endoscopic ultrasound, and fine-needle aspiration.
- Treatment involved pelvic radiation, chemotherapy, abdominoperineal resection, and a Whipple procedure.
Main Results:
- Rectal adenocarcinoma was confirmed, with staging revealing a 5-cm cystic pancreatic lesion consistent with metastasis.
- The patient underwent a multi-modal treatment approach including surgery and chemotherapy.
- Histopathological analysis confirmed metastatic colorectal adenocarcinoma with high-risk features but negative surgical margins.
Conclusions:
- Surgical resection is the cornerstone of treatment for secondary pancreatic cancer, regardless of the primary tumor's origin.
- Resection is associated with improved palliation and more favorable survival outcomes.
- Further studies on secondary pancreatic cancer are needed, but current evidence supports aggressive surgical management.
